All news
Low ImpactPharma

Syncom Formulations attracts investor attention on NSE

simplywall.stRead the original26 May 2026

Syncom Formulations attracts investor attention on NSE due to increased retail interest and positive sentiment. The stock has seen a 15% rise in the past week, outperforming sector benchmarks. Trading volumes surged to 2.3x average, indicating momentum buildup. Fundamentally, it remains a small-cap with moderate revenue growth.

📊 STOCKS: SYNCOMF | 🏢 SECTOR: Pharma | #LOWIMPACT #Pharma

#Pharma#SmallCap#InvestorSentiment
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.